The Brighterside of News on MSN
For the first time ever, researchers made a photon travel back in time
Shattered glass does not leap back into your hand. Smoke from a match does not gather itself and crawl back inside. In ...
The partners said a TROP2-targeting antibody drug conjugate succeeded in a late-stage trial, paving the way for potential ...
Cancer-fighting antibody drugs are designed to penetrate tumor cells and release a lethal payload deep within, but too often ...
Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...
Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell ...
Kelun Biotech's sac-TMT plus Merck's Keytruda shows significant progress in late-stage lung cancer trial. Read more here.
With a phase 3 win for a combination of its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) ...
If you live with diabetes, your day is punctured by sharp little rituals: pens, syringes, infusion sets, or fingersticks. Now ...
An investigator-developed drug has shown preclinical efficacy and is worth testing in clinical trials in aggressive breast ...
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Conjugation-mediated DNA delivery is the ...
The delivery of nucleic acids requires a gene vector as they are unable to effectively cross cell membranes. Polycations and deoxyribonucleic acid (DNA) can self-assemble into polyplexes enabling ...
A new study by Tel Aviv University reveals how bacterial defense mechanisms can be neutralized, enabling the efficient transfer of genetic material between bacteria. The researchers believe this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback